Original Article
May it be a new parameter of 18F-FDG PET/CT for differentiating between benign and malignant adrenal lesions: “Adrenal Densitometabolic Index (ADMI)”
¿Puede ser un nuevo parámetro de la PET/TC 18F-FDG para diferenciar entre lesiones suprarrenales benignas y malignas: “Índice Densitometabólico Suprarrenal (IDMS)”?
a Sakarya University Medical School, Research and Training Hospital, Department of Nuclear Medicine, Sakarya, Turkey
b Marmara University Medical School, Pendik Research and Training Hospital, Department of Nuclear Medicine, İstanbul, Turkey
c Ağrı Training and Research Hospital, Department of Nuclear Medicine, Ağrı, Turkey
d Çanakkale Onsekiz Mart University Medical School, Department of Nuclear Medicine
